Author(s):
Vinod K. Matole, Pranita Kokare, Vaishnavi S. Vhatte
Email(s):
matole7414@gmail.com
DOI:
10.52711/2349-2988.2026.00042 
Address:
Vinod K. Matole, Pranita Kokare, Vaishnavi S. Vhatte
Shivai Charitable Trust’s College of Pharmacy, Koregaonwadi Tq. Omerga, Dist. Dharashiv 413606, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 3,
Year - 2026
ABSTRACT:
Invasomes are soft nanovesicles made of phospholipids, ethanol, and terpenes. These components help the vesicles penetrate the skin effectively and deliver drugs into deeper skin layers. One of the major advantages of invasomes is their ability to enhance drug permeation through the skin while reducing drug absorption into the bloodstream. This helps to increase the local therapeutic effect and minimize systemic side effects. Due to these properties, invasomes have emerged as a promising carrier system for transdermal and dermal drug delivery. This review discusses their structure, penetration mechanism, characterization methods, applications, and advantages in skin drug delivery. It emphasizes their ability to overcome biological barriers, improve drug bioavailability, and enhance therapeutic efficacy. With further research and development, invasomes hold great promise as an innovative drug delivery system, offering numerous opportunities for advancements in medical treatments and patient care.
Cite this article:
Vinod K. Matole, Pranita Kokare, Vaishnavi S. Vhatte. Invasomes in the Era of Smart Transdermal Therapeutics: From Molecular Design to Clinical Translation. Research Journal of Science and Technology. 2026; 18(3):299-4. doi: 10.52711/2349-2988.2026.00042
Cite(Electronic):
Vinod K. Matole, Pranita Kokare, Vaishnavi S. Vhatte. Invasomes in the Era of Smart Transdermal Therapeutics: From Molecular Design to Clinical Translation. Research Journal of Science and Technology. 2026; 18(3):299-4. doi: 10.52711/2349-2988.2026.00042 Available on: https://rjstonline.com/AbstractView.aspx?PID=2026-18-3-9
REFERENCE:
1. Paudel, K.S.; Milewski, M.; Swadley, C.L.; Brogden, N.K.; Ghosh, P.; Stinchcomb, A.L. Challenges and opportunities in dermal/transdermal delivery. Ther. Deliv. 2010; 1: 109–131.
2. Ashtikar, M.; Langelüddecke, L.; Fahr, A.; Deckert, V. Tip-enhanced Raman scattering for tracking of invasomes in the stratum corneum. Biochim. Et Biophys. Acta (Bba)-Gen. Dragicevic-Curic, N., Gräfe, S., Gitter, B., Winter, S., and Fahr, A. Surface charged temoporfin-loaded flexible vesicles: In vitro skin penetration studies and stability. International Journal of Pharmaceutics. 2008; 359(1–2): 15–22.
3. Verma, D. D., and Fahr, A. Synergistic penetration effect of ethanol and phospholipids on the topical delivery of cyclosporin A. Journal of Controlled Release. 2004; 97(1): 55–66.
4. Elsayed, M. M., Abdallah, O. Y., Naggar, V. F., and Khalafallah, N. M. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie. 2007; 62(2): 133–137.
5. Dragicevic-Curic, N., Scheglmann, D., Albrecht, V., and Fahr, A. Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies. Journal of Controlled Release. 2008; 127(1): 59–69. Subj. 2017, 1861, 2630–2639.
6. Dragicevic-Curic N, Winter S, Stupar M, Milic J, Krajišnik D, Fahr A. Development of temoporfin-loaded invasomes for dermal delivery. International Journal of Pharmaceutics. 2009; 384(1–2): 100–108.
7. Hope MJ, Bally MB, Webb G, Cullis PR. Production of large unilamellar vesicles by rapid extrusion. Biochimica et Biophysica Acta. 1985; 812(1): 55–65.
8. Gupta A, Prajapati SK, Balamurugan M, Singh M, Bhatia D. Design and development of invasomal systems for transdermal drug delivery: A review. Journal of Drug Delivery Science and Technology. 2021; 61: 102316.
9. Abdallah MH. Invasomes as a novel vesicular carrier for transdermal drug delivery: Recent advances and future perspectives. Drug Delivery and Translational Research. 2020; 10(6): 1821–1838.
10. S. Babaie, A.R.D. Bakhshayesh, J.W. Ha, H. Hamishehkar, KH. Kim, Invasome: a novel nanocarrier for transdermal drug delivery, Nanomaterials. 2020; 10(2): 341, https://doi.org/10.3390/nano10020341.
11. M. Kamran, A. Ahad, M. Aqil, S.S. Imam, Y. Sultana, A. Ali, Design, formulation and optimization ofnovel soft nano-carriers for transdermal olmesartan medoxomil delivery: in vitro characterization and invivo pharmacokinetic assessment, Int. J. Pharm. 2016; 505(1-2): 147–158, https://doi.org/10.1016/j. ijpharm.2016.03.030.